Eton Pharmaceuticals, Inc. (ETON) Total liabilities 2019–2025
Eton Pharmaceuticals, Inc. (ETON) total liabilities at each fiscal year-end, per SEC filings.
$66.0MFY2025 · since FY2019: $6.5M → $66.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $66.0M | +27.6% |
| FY2024 | $51.7M | +217.9% |
| FY2023 | $16.3M | +36.1% |
| FY2022 | $12.0M | +21.5% |
| FY2021 | $9.8M | -7.7% |
| FY2020 | $10.7M | +63.4% |
| FY2019 | $6.5M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice